NO323849B1 - Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid. - Google Patents

Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid. Download PDF

Info

Publication number
NO323849B1
NO323849B1 NO19964721A NO964721A NO323849B1 NO 323849 B1 NO323849 B1 NO 323849B1 NO 19964721 A NO19964721 A NO 19964721A NO 964721 A NO964721 A NO 964721A NO 323849 B1 NO323849 B1 NO 323849B1
Authority
NO
Norway
Prior art keywords
hgv
seq
hepatitis
polypeptide
virus
Prior art date
Application number
NO19964721A
Other languages
English (en)
Norwegian (no)
Other versions
NO964721D0 (no
NO964721L (no
Inventor
Jungsuh P Kim
Kirk F Fry
Lavonne Marie Young
Jeffrey M Linnen
John Wages
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of NO964721D0 publication Critical patent/NO964721D0/no
Publication of NO964721L publication Critical patent/NO964721L/no
Publication of NO323849B1 publication Critical patent/NO323849B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
NO19964721A 1994-05-20 1996-11-07 Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid. NO323849B1 (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US24698594A 1994-05-20 1994-05-20
US28555894A 1994-08-03 1994-08-03
US28554394A 1994-08-03 1994-08-03
US32972994A 1994-10-26 1994-10-26
US34427194A 1994-11-23 1994-11-23
US35750994A 1994-12-16 1994-12-16
US38988695A 1995-02-15 1995-02-15
PCT/US1995/006169 WO1995032291A2 (en) 1994-05-20 1995-05-19 Hepatitis g virus and molecular cloning thereof

Publications (3)

Publication Number Publication Date
NO964721D0 NO964721D0 (no) 1996-11-07
NO964721L NO964721L (no) 1997-01-17
NO323849B1 true NO323849B1 (no) 2007-07-09

Family

ID=27569460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964721A NO323849B1 (no) 1994-05-20 1996-11-07 Hepatitt G virus, polynukleotid, vektor, antistoff, antigen, anvendelse av nevnte antigen samt fremgangsmate for fremstilling av et hepatitt G virus polypeptid.

Country Status (16)

Country Link
EP (1) EP0763114B1 (sv)
JP (2) JPH10503642A (sv)
KR (1) KR100394693B1 (sv)
CN (1) CN1125877C (sv)
AT (1) ATE210185T1 (sv)
CA (1) CA2190860A1 (sv)
DE (1) DE69524407T2 (sv)
DK (1) DK0763114T3 (sv)
ES (1) ES2170152T3 (sv)
FI (1) FI112249B (sv)
HK (1) HK1012412A1 (sv)
MX (1) MX9605666A (sv)
NO (1) NO323849B1 (sv)
NZ (1) NZ288000A (sv)
PT (1) PT763114E (sv)
WO (1) WO1995032291A2 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
US5709997A (en) * 1995-08-14 1998-01-20 Abbott Laboratories Nucleic acid detection of hepatitis GB virus
WO1997019195A1 (de) * 1995-11-21 1997-05-29 Boehringer Mannheim Gmbh Amplifikation von nukleinsäuren und nachweis eines neuen hepatitis-nona/nonb/nonc/nond/none-virus
IT1283893B1 (it) * 1996-01-24 1998-05-07 Sorin Biomedica Diagnostics Sp Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni
DE19613406A1 (de) * 1996-04-03 1997-10-09 Boehringer Mannheim Gmbh Expression von HGV-Antigenen und deren Verwendung
IT1284630B1 (it) * 1996-04-17 1998-05-21 Sorin Biomedica Diagnostics Sp Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
US5766916A (en) * 1996-04-24 1998-06-16 Genelabs Technologies, Inc. Hepatitis G virus protease
US6020195A (en) * 1996-09-18 2000-02-01 Roche Diagnostics Gmbh Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent
AU752131C (en) * 1997-11-06 2003-12-04 Innogenetics N.V. Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
GB0009756D0 (en) * 2000-04-19 2000-06-07 Glaxo Group Ltd Test method
WO2014097762A1 (ja) * 2012-12-20 2014-06-26 国立大学法人熊本大学 高病原性トリインフルエンザに対する抗体
US9594163B2 (en) 2013-04-15 2017-03-14 Electronics And Telecommunications Research Institute Security and surveillance system and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4046489A (en) * 1988-07-06 1990-02-05 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
WO1994018217A1 (en) * 1993-02-03 1994-08-18 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO1995021922A2 (en) * 1994-02-14 1995-08-17 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use

Also Published As

Publication number Publication date
KR100394693B1 (ko) 2003-12-31
NZ288000A (en) 1998-09-24
NO964721D0 (no) 1996-11-07
AU684177B2 (en) 1997-12-04
CA2190860A1 (en) 1995-11-30
PT763114E (pt) 2002-05-31
KR970703425A (ko) 1997-07-03
CN1125877C (zh) 2003-10-29
ATE210185T1 (de) 2001-12-15
NO964721L (no) 1997-01-17
HK1012412A1 (en) 1999-07-30
JP4296174B2 (ja) 2009-07-15
AU2689595A (en) 1995-12-18
ES2170152T3 (es) 2002-08-01
MX9605666A (es) 1998-05-31
JPH10503642A (ja) 1998-04-07
FI964605A0 (sv) 1996-11-18
FI112249B (sv) 2003-11-14
DE69524407D1 (de) 2002-01-17
DK0763114T3 (da) 2002-04-02
CN1153529A (zh) 1997-07-02
EP0763114A2 (en) 1997-03-19
DE69524407T2 (de) 2002-08-01
WO1995032291A2 (en) 1995-11-30
FI964605A (sv) 1997-01-15
EP0763114B1 (en) 2001-12-05
JP2006115845A (ja) 2006-05-11
WO1995032291A3 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
JP4296174B2 (ja) Ｇ型肝炎ウイルスおよびその分子クローニング
US5766840A (en) Hepatitis G virus and molecular cloning thereof
JP2662358B2 (ja) Ｎａｎｂｖの診断用薬
EP0998567B1 (en) Cloned genomes of infectious hepatitis c viruses and uses thereof
CA2065287C (en) New hcv isolates
JP2656995B2 (ja) Ｎａｎｂｖの診断用薬
Tsukiyama-Kohara et al. Antigenicities of group I and II hepatitis C virus polypeptides—molecular basis of diagnosis
US7348011B2 (en) Hepatitis C virus vaccine
WO1995021922A2 (en) Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO1995032292A2 (en) Detection of viral antigens coded by reverse-reading frames
US5874563A (en) Hepatitis G virus and molecular cloning thereof
DK175975B1 (da) NANBV-diagnostika og -vacciner
US20020119447A1 (en) Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use
AU684177C (en) Hepatitis G virus and molecular cloning thereof
DK176280B1 (da) NANBV-diagnostika og -vacciner
KR100187483B1 (ko) Hcv 폴리뉴클레오티드 및 그 사용
EP0745129A1 (en) Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees